Palliative Care and Symptom Management for the Pediatric Oncology Patient

April 7, 2016 updated by: M.D. Anderson Cancer Center

The goal of this study is to learn about the communication, decision-making, symptom management, emotional adjustment, and spiritual needs of parents and pediatric patients treated at the Children's Cancer Hospital at M. D. Anderson (MCACC).

Primary Objectives:

  1. Determine the palliative care service needs of pediatric cancer patients and their parents, including communication, decision-making, symptom management, emotional and spiritual support when receiving treatment for early cancer, treatment for advanced disease, and treatment in the end-of-life period.
  2. Identify intra-group differences in the categories listed in Objective 1 for pediatric cancer patients receiving treatment (a) for early cancer, (b) for advanced disease, and (c) at end-of-life.

Secondary Objectives:

1. Inform the development of a Pediatric Palliative Care Program at the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center (MCACC or MDACC) based on identified needs as determined by primary study aims 1 and 2.

Study Overview

Detailed Description

PARENT:

The Focus Group:

If you agree to take part in this study, you will attend a 1 1/2 hour group session with 3-9 other caregivers. The group will be led by a group leader and an assistant. The group leader will ask questions to the group about communication, decision-making, symptom management, emotional adjustment, and spirituality experiences and needs during your child's treatment. If you have a child who is also taking part in this study, you will meet separately from your child.

At the time of your arrival and before the beginning of the focus group session, you will be asked to complete a questionnaire. You will be asked about you and your child's age, sex, where you live, your religion (if any), your ethnicity and race, and if there are other children in the family. You will be asked about when you found out your child had cancer, the type of cancer, and when the cancer got worse or came back (if applicable). You will be asked whether others have shared parenting responsibilities, your education level, and if you work and what type of work you do. The questionnaire will take about 5 minutes to complete.

Audiotapes/Transcripts:

The assistant will take notes and the session will be recorded on an audiotape. All audiotapes will be stored in locked cabinets maintained by the study chair. The audiotapes will be destroyed once the study and analyses are complete.

The audiotape will be recorded onto paper "transcripts". The completed focus group transcriptions will be placed in a database secured with a password and identification protected. Transcribed results will have all identifiable markers removed and kept in the investigators' locked files. Only the researchers will be able to view the transcriptions.

Length of Study:

Your participation on this study is complete once you finish the group meeting.

PEDIATRIC PARTICIPANT:

The Focus Group:

If you agree to take part in this study, you will go to a 1 1/2 hour group session with 3-9 other patients. The group will be led by a group leader and an assistant. The group leader will ask questions to the group about who you talk with about the disease, how you make a decision, how you manage any symptoms you may have, how you are feeling about the disease, and how religion has helped you during your treatment. If your parent is also taking part in this study, you will meet separately from your parent.

At the time of your arrival and before the beginning of the focus group session, your parent will be asked to complete a questionnaire. Your parent will be asked about their age and sex, your age and sex, where you live, your religion (if any), your ethnicity and race, and if there are other children in the family. Your parent will be asked when they found out you had cancer, the type of cancer, and when the cancer got worse or came back (if applicable). Your parent will be asked whether others have shared parenting responsibilities, their education level, and if they work and about the type of work they do. The questionnaire will take about 5 minutes to complete.

Audiotapes/Transcripts:

The assistant will take notes and the session will be recorded on an audiotape. All audiotapes will be stored in locked cabinets taken care of by the study chair. The audiotapes will be destroyed once the study is over and the researchers have finished looking at the information.

The audiotape will be recorded onto paper "transcripts". The completed focus group transcriptions will be placed in a database secured with a password and identification protected. Any personal information about you will be removed from these papers and the papers will be kept in the investigators' locked files. Only the researchers will be able to view the transcriptions.

Length of Study:

Your participation on this study is over once you complete the focus group.

Study Type

Observational

Enrollment (Actual)

13

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas MD Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Study participants 10-18 years of age with cancer and their parent(s) or caregiver(s).

Description

Inclusion Criteria:

Inclusion for Children:

  • 10-18 years of age
  • MD Anderson Children's Cancer Center (MCACC) cancer patient
  • receiving anti-cancer treatment for disease that is not recurrent or metastatic for cancer diagnosed in the past 3-12 mos or receiving anti-cancer treatment for recurrent or metastatic cancer diagnosed within the past 3-12 months
  • speak & understand English
  • reside in the Greater Houston area
  • provide IRB-approved pediatric assent or informed consent, as age appropriate
  • if < 18 years of age, provide Internal Review Board (IRB)-approved parental permission
  • child's eligibility is not contingent upon parent's decision to participate

Inclusion for parents:

  • self-identified parent(s) that has(have) a child eligible for study, per the inclusion and exclusion criteria noted above or has had a child (0-18 yrs of age at time of death) treated for cancer at MCACC who has died in the last 1 to 2 years
  • speak and understand English
  • reside in the Houston metropolitan area
  • provide IRB-approved informed consent
  • attend different focus groups if more than one eligible parent per child (max 2 parents per child)
  • parent's eligibility is not contingent upon the child's decision to participate

Exclusion Criteria:

Exclusion for Children:

  • have cognitive impairment, developmental delay, or emotional distress that would limit participation in a group discussion, as determined by the clinical judgment of the investigator
  • younger than 10 years or older than 18 years of age

Exclusion for Caregiver:

  • have cognitive impairment, developmental delay, or emotional distress that would limit participation in a group discussion, as determined by the clinical judgment of the investigator.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1
Early cancer group-children ages 10-13 years
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
Group 2
Early cancer group-children ages 14 to 18 years
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
Group 3
Early cancer group-parents of patients ages 10-18 years
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
Group 4
Advanced cancer group-children ages 10-13 years
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
Group 5
Advanced cancer group-children ages 14-18 years
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
Group 6
Advanced cancer group-parents of children ages 10-18 years
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
Group 7
End of life group - parents of children ages birth to 18 years of age at time of death
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Palliative Care Service Needs of Pediatric Cancer Patients + Their Parents
Time Frame: 3 Years
Qualitative data collection.
3 Years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2008

Primary Completion (ACTUAL)

April 1, 2016

Study Registration Dates

First Submitted

May 7, 2008

First Submitted That Met QC Criteria

May 8, 2008

First Posted (ESTIMATE)

May 9, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

April 8, 2016

Last Update Submitted That Met QC Criteria

April 7, 2016

Last Verified

April 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Cancers

Clinical Trials on Focus Group - Parent/Caregiver

3
Subscribe